Description
Identification of therapeutically relevant gene mutations for Myeloid cancerCancer
OncQuer TM Myeloid Panel (1-3 markers)
Identification of therapeutically relevant gene mutations for Myeloid cancerCancer
TAT:
Specimen Type:
Genomics Panel Test
Other Tests
- 263%
-
238%
Clinical Exome Test
multi gene panel. Gene list will be shared on request
-
264%
OncQuer TM Scout LB EGFR Resistance Test
Identification gene mutations leading to resistance to EGFR therapy
OncQuer TM Scout LB EGFR Resistance Test
Identification gene mutations leading to resistance to EGFR therapy
-
264%
OncQuer(TM) CML panel
Identification of therapeutically relevant gene mutations for Myeloid cancerCancer
OncQuer(TM) CML panel
Identification of therapeutically relevant gene mutations for Myeloid cancerCancer
Reviews
There are no reviews yet.